inVentiv Medical Management Receives Health Utilization Management Accreditation

CHARLOTTE, N.C., July 30, 2012 /PRNewswire/ -- inVentiv Medical Management (iMM), an inVentiv Health company and provider of best-in-class medical management services to consumers and the healthcare industry, announced today that it has received Health Utilization Management (HUM) accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

A leader in HUM accreditation, URAC's standards ensure that organizations follow a process that is clinically sound and respects patients and providers' rights, while giving payers reasonable guidelines to follow. The organization's standards address the use of evidence-based guidelines, incorporation of adherence guidelines and evaluation of utilization rates to meet the demands of a changing healthcare system.

"By applying for and receiving Health Utilization Management accreditation, inVentiv Medical Management has demonstrated a commitment to quality healthcare," said Alan P. Spielman, URAC president and CEO. "Quality healthcare is crucial to our nation's welfare, and it is important to have organizations that are willing to measure themselves against national standards."

Marc Palmer, CEO of iMM, said: "inVentiv Medical Management is honored to receive Health Utilization Management accreditation from URAC. This accreditation demonstrates our commitment to meeting national standards for utilization management excellence and the needs of our clients, as well as those of patients, payers and providers. We look forward to working with URAC to receive additional accreditations in the future."

iMM also announced today that it has moved its corporate headquarters from Augusta, Georgia to a 9,500-square-foot space in Charlotte, North Carolina. The new headquarters – located in the Everett Building in Ballantyne Corporate Park – will enhance iMM's ability to reach clients quickly and foster close collaborations with them. While core clinical staff and operations will remain in Augusta, the Charlotte office will support iMM's business development efforts.

"Moving our headquarters to Charlotte will help us be more accessible to our clients and ensure that we remain nimble to their business needs," Palmer added. "With multiple locations, we will be able to more effectively support the growing interest in our outcomes-focused suite of services, including our Accountable Care Solutions focused on comprehensive oncology, cardiovascular and kidney care management."

About URAC
URAC, an independent, nonprofit organization, is a leader in promoting health care quality through accreditation and certification programs. URAC's standards keep pace with the rapid changes in the health care system, and provide a mark of distinction for health care organizations to demonstrate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in setting meaningful standards for the health care industry. For more information, visit www.urac.org.

About Accountable Care Solutions Powered by inVentiv Medical Management™
Accountable Care Solutions Powered by inVentiv Medical Management, provides customers with a dedicated staff of specialty care physicians, nurses and billing experts who use evidence-based standards to evaluate and enhance the delivery of medical care to patients with some of the most complex and costly health conditions. iMM's suite of Accountable Care Solutions includes Comprehensive Oncology Care Management, Comprehensive Cardiovascular Care Management and Comprehensive Kidney Care Management.

About inVentiv Medical Management
inVentiv Medical Management, an inVentiv Health company, is a leading national provider of physician-directed, nurse-supported, technology-enabled, medical management solutions to third party administrators, self-funded or fully insured plans, employer groups, managing general underwriters, Accountable Care Organizations (ACOs) and insurance carriers. With a mission of improving healthcare costs, quality and outcomes, we deliver balanced clinical surveillance and cost intervention that supports payers, providers and patients. inVentiv Medical Management is headquartered in Charlotte, North Carolina. Please visit http://www.inventivmm.com for more information.

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees in 40 countries, inVentiv rapidly transforms promising ideas into commercial reality. inVentiv Health Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause our performance to differ materially. These forward-looking statements reflect our current views about future events and are subject to risks, uncertainties and assumptions. We wish to caution readers that certain important factors may have affected and could in the future affect our actual results and could cause actual results to differ significantly from those expressed in any forward-looking statement. Such factors include, without limitation: the impact of our substantial level of indebtedness on our ability to generate sufficient cash to fulfill our obligations under our existing debt instruments or our ability to incur additional indebtedness; the impact of the consummation of any announced and future acquisitions; the impact of any additional leverage we may incur in connection with the financing of acquisitions, on our ratings and the ratings of our debt securities; our ability to sufficiently increase our revenues and maintain or decrease expenses and cash capital expenditures to permit us to fund our operations; our ability to continue to comply with the covenants and terms of our senior secured credit facilities and to access sufficient capital under our credit agreement or from other sources of debt or equity financing to fund our operations; the impact of any default by any of our credit providers; our ability to accurately forecast costs to be incurred in providing services under fixed price contracts; our ability to accurately forecast insurance claims within our self- insured programs; the potential impact of pricing pressures on pharmaceutical manufacturers from future healthcare reform initiatives or from changes in the reimbursement policies of third-party payers; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; the potential impact of financial, economic, political and other risks, including interest rate and exchange rate risks, related to conducting business internationally; our ability to successfully operate new lines of business; our ability to manage our infrastructure and resources to support our growth; our ability to successfully identify new businesses to acquire, conclude acquisition negotiations and integrate the acquired businesses into our operation, and the resulting synergies; the resolution of purchase price adjustment disputes in connection with our recent acquisitions and related impacts; any disruptions, impairments, or malfunctions affecting software as well as excessive costs or delays that may adversely impact our continued investment in and development of software; the potential impact of government regulation on us and on our client base; our ability to comply with all applicable laws as well as our ability to successfully implement from a timing and cost perspective any changes in applicable laws; our ability to recruit, motivate and retain qualified personnel, including sales representatives; the possibility that client agreements will be terminated or not renewed; any potential impairment of goodwill or intangible assets; consolidation in the pharmaceutical industry; changes in trends in the healthcare and pharmaceutical industries or in pharmaceutical outsourcing, including initiatives by our clients to perform services we offer internally; the impact of customer project delays and cancellations; our ability to convert backlog into revenue; the potential liability associated with bringing new drugs to market, including potential liability from injury to clinical trial participants; the actual impact of the adoption of certain accounting standards; and our ability to maintain technological advantages in a variety of functional areas, including sales force automation, electronic claims surveillance and patient compliance. Holders of our debt instruments are referred to reports provided to investors from time to time and the offering memorandums provided in connection with the issuance of our senior secured notes for further discussion of these risks and other factors.

SOURCE inVentiv Medical Management